Tuesday, August 18, 2020 8:46:47 PM
Recent EIGR News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:03:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:59:31 PM
- Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan • PR Newswire (US) • 01/18/2024 10:49:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:45:31 PM
- Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split • PR Newswire (US) • 01/04/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2023 09:01:29 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/04/2023 11:01:01 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 09:02:55 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/24/2023 11:01:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:01:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:27:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:14:46 PM
- Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update • PR Newswire (US) • 11/09/2023 09:05:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/03/2023 01:54:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 01:14:42 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 08:51:30 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/20/2023 08:29:11 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 09/28/2023 08:54:38 PM
- Eiger BioPharmaceuticals to Discontinue Chronic Hepatitis Delta Study, Ends Licensing Talks • Dow Jones News • 09/12/2023 09:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:42:01 PM
- Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta • PR Newswire (US) • 09/12/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 01:38:59 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 01:35:36 AM
- Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 09/05/2023 08:05:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM